Similar articles for PMID: 31694713

Year	Number of Results
2004	1
2007	3
2008	2
2009	2
2010	1
2011	2
2012	4
2013	8
2014	9
2015	17
2016	11
2017	14
2018	17
2019	17
2020	2
2021	2
2022	3
2024	0

1

Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS.

van der Heijde D, Landewé R. van der Heijde D, et al. Arthritis Res Ther. 2019 Nov 6;21(1):225. doi: 10.1186/s13075-019-2045-1. Arthritis Res Ther. 2019. PMID: 31694713 Free PMC article.

2

Can structural damage be prevented in ankylosing spondylitis?

Sieper J. Sieper J. Curr Opin Rheumatol. 2009 Jul;21(4):335-9. doi: 10.1097/BOR.0b013e32832c668a. Curr Opin Rheumatol. 2009. PMID: 19424070 Review.

3

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

van der Heijde D, Salonen D, Weissman BN, Landewé R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R; Canadian (M03-606) study group; ATLAS study group. van der Heijde D, et al. Arthritis Res Ther. 2009;11(4):R127. doi: 10.1186/ar2794. Epub 2009 Aug 24. Arthritis Res Ther. 2009. PMID: 19703304 Free PMC article.

4

Anti-tumor Necrosis Factor Therapy Increased Spine and Femoral Neck Bone Mineral Density of Patients with Active Ankylosing Spondylitis with Low Bone Mineral Density.

Li H, Li Q, Chen X, Ji C, Gu J. Li H, et al. J Rheumatol. 2015 Aug;42(8):1413-7. doi: 10.3899/jrheum.150019. Epub 2015 Jun 15. J Rheumatol. 2015. PMID: 26077412 Clinical Trial.

5

Adalimumab for the treatment of ankylosing spondylitis.

Sieper J, Rudwaleit M, Braun J. Sieper J, et al. Expert Opin Pharmacother. 2007 Apr;8(6):831-8. doi: 10.1517/14656566.8.6.831. Expert Opin Pharmacother. 2007. PMID: 17425478

6

TNF-alpha inhibitors for ankylosing spondylitis.

Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P, Wells GA. Maxwell LJ, et al. Cochrane Database Syst Rev. 2015 Apr 18;(4):CD005468. doi: 10.1002/14651858.CD005468.pub2. Cochrane Database Syst Rev. 2015. PMID: 25887212 Review.

7

Continuous Improvement of Physical Functioning in Ankylosing Spondylitis Patients by Tumor Necrosis Factor Inhibitors: Three-Year Followup and Predictors.

van Weely SF, Kneepkens EL, Nurmohamed MT, Dekker J, van der Horst-Bruinsma IE. van Weely SF, et al. Arthritis Care Res (Hoboken). 2016 Oct;68(10):1522-9. doi: 10.1002/acr.22869. Epub 2016 Aug 19. Arthritis Care Res (Hoboken). 2016. PMID: 26881893 Free article.

8

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.

van der Heijde D, Breban M, Halter D, DiVittorio G, Bratt J, Cantini F, Kary S, Pangan AL, Kupper H, Rathmann SS, Sieper J, Mease PJ. van der Heijde D, et al. Rheumatology (Oxford). 2015 Jul;54(7):1210-9. doi: 10.1093/rheumatology/keu438. Epub 2014 Dec 25. Rheumatology (Oxford). 2015. PMID: 25541333 Free PMC article. Clinical Trial.

9

Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies.

Maas F, Spoorenberg A, Brouwer E, van der Veer E, Bootsma H, Bos R, Wink FR, Arends S. Maas F, et al. Semin Arthritis Rheum. 2017 Apr;46(5):562-568. doi: 10.1016/j.semarthrit.2016.11.003. Epub 2016 Nov 9. Semin Arthritis Rheum. 2017. PMID: 28040243

10

Effects of tumor necrosis factor-α inhibitors on new bone formation in ankylosing spondylitis.

Zhang JR, Liu XJ, Xu WD, Dai SM. Zhang JR, et al. Joint Bone Spine. 2016 May;83(3):257-64. doi: 10.1016/j.jbspin.2015.06.013. Epub 2015 Dec 9. Joint Bone Spine. 2016. PMID: 26678001 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year